Helping people in methadone treatment quit smoking and other drugs
Motivational Interviewing and Mindfulness-Oriented Recovery Enhancement for Tobacco Dependence and Other Drug use in Methadone Treatment
This study is looking for people in methadone treatment for opioid use who also smoke, to try out a new 8-week group program that teaches mindfulness and emotional skills to help them feel better and reduce their chances of relapsing into substance use.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-10589481 on NIH RePORTER |
What this research studies
This research focuses on individuals undergoing methadone treatment for opioid use disorder, particularly those who also smoke tobacco. It aims to implement a novel behavioral intervention called Mindfulness-Oriented Recovery Enhancement (MORE), which combines mindfulness training and emotional regulation techniques over an 8-week group therapy program. The goal is to address the intertwined issues of tobacco and substance use by improving motivation and self-efficacy, ultimately reducing relapse rates. Participants will engage in activities designed to enhance their emotional well-being and reward processing, which are often disrupted in those with substance use disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals receiving methadone treatment for opioid use disorder who also smoke cigarettes or use other substances.
Not a fit: Patients who are not currently undergoing methadone treatment or do not have a dual diagnosis of opioid and tobacco use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment strategies for individuals struggling with both opioid and tobacco dependence, improving their chances of recovery.
How similar studies have performed: Previous research has shown promise for mindfulness-based interventions in substance use treatment, but this specific approach targeting polysubstance use in methadone patients is novel.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Cooperman, Nina — Rutgers Biomedical and Health Sciences
- Study coordinator: Cooperman, Nina
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.